tiprankstipranks
Advertisement
Advertisement

HQY Stock Latest News

HealthEquity Adds Sanford Health CEO Bill Gassen to Board
Company AnnouncementsHealthEquity Adds Sanford Health CEO Bill Gassen to Board
6d ago
8K
HQY
HealthEquity price target raised to $128 from $120 at Deutsche Bank
PremiumThe Fly
HealthEquity price target raised to $128 from $120 at Deutsche Bank
17d ago
HQY
HealthEquity Inc. Earnings Call Highlights Profitable Growth
PremiumCompany Announcements
HealthEquity Inc. Earnings Call Highlights Profitable Growth
18d ago
HQY
HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target
PremiumRatings
HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target
18d ago
HQY
HealthEquity price target lowered to $110 from $125 at Barrington
PremiumThe Fly
HealthEquity price target lowered to $110 from $125 at Barrington
18d ago
HQY
HealthEquity price target lowered to $100 from $110 at RBC Capital
PremiumThe FlyHealthEquity price target lowered to $100 from $110 at RBC Capital
18d ago
HQY
HealthEquity price target lowered to $123 from $129 at JPMorgan
Premium
The Fly
HealthEquity price target lowered to $123 from $129 at JPMorgan
18d ago
HQY
HealthEquity reports Q4 EPS 95c, consensus 90c
Premium
The Fly
HealthEquity reports Q4 EPS 95c, consensus 90c
19d ago
HQY
HealthEquity sees FY27 EPS $4.56-$4.65, consensus $4.54
PremiumThe Fly
HealthEquity sees FY27 EPS $4.56-$4.65, consensus $4.54
19d ago
HQY
Notable companies reporting after market close
PremiumThe Fly
Notable companies reporting after market close
19d ago
HQY
LULU
Is HQY a Buy, Before Earnings?
PremiumPre-Earnings
Is HQY a Buy, Before Earnings?
21d ago
HQY
HealthEquity price target lowered to $85 from $100 at BMO Capital
PremiumThe Fly
HealthEquity price target lowered to $85 from $100 at BMO Capital
1M ago
HQY
HealthEquity price target lowered to $108 from $120 at Jefferies
PremiumThe FlyHealthEquity price target lowered to $108 from $120 at Jefferies
2M ago
HQY
HealthEquity: Above-Consensus HSA Growth and Cautious Valuation Support Buy Rating
Premium
Ratings
HealthEquity: Above-Consensus HSA Growth and Cautious Valuation Support Buy Rating
2M ago
HQY
HealthEquity price target lowered to $110 from $118 at Barclays
Premium
The Fly
HealthEquity price target lowered to $110 from $118 at Barclays
2M ago
HQY
HealthEquity backs FY26 EPS view $3.87-$3.95, consensus $3.95
PremiumThe Fly
HealthEquity backs FY26 EPS view $3.87-$3.95, consensus $3.95
2M ago
HQY
HealthEquity backs FY27 revenue view $1.38B-$1.41B, consensus $1.41B
PremiumThe Fly
HealthEquity backs FY27 revenue view $1.38B-$1.41B, consensus $1.41B
2M ago
HQY
HealthEquity reports HSAs as of January 31 10.6M, up 7%
PremiumThe Fly
HealthEquity reports HSAs as of January 31 10.6M, up 7%
2M ago
HQY
HealthEquity price target lowered to $110 from $130 at BTIG
PremiumThe Fly
HealthEquity price target lowered to $110 from $130 at BTIG
2M ago
HQY
HealthEquity price target lowered to $100 from $120 at Raymond James
PremiumThe FlyHealthEquity price target lowered to $100 from $120 at Raymond James
2M ago
HQY
HealthEquity: Conservative Guidance, Custodial Yield Tailwinds, and Efficiency Gains Support Buy-Rated Upside
Premium
Ratings
HealthEquity: Conservative Guidance, Custodial Yield Tailwinds, and Efficiency Gains Support Buy-Rated Upside
3M ago
HQY
HealthEquity Issues Confident Fiscal 2027 Outlook and Guidance
Premium
Company Announcements
HealthEquity Issues Confident Fiscal 2027 Outlook and Guidance
3M ago
8K
HQY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >